K. Ozawa

The Effect of CAPD on Lipid Abnormalities Detected by Apoproteins and Ultracentrifugal Lipid Subfractions

T. Sasaoka, T. Akiba, I. Nakayama, 1986 .

Remarkable improvement of activity by CAPD in a hemodialysis patient with a pseudotumor of the craniocervical junction.

T. Sasaoka, T. Tamura, T. Togo, 1992, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).

T. Akiba, J. Takeuchi, T. Shinoda, 1981, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[Clinical study of coagulopathy in renal failure. 1. Vitamin K-deficient hemorrhage].

T. Sasaoka, I. Nakayama, Y. Kijima, 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.

F. Marumo, T. Akiba, M. Hoshino, 1992, ASAIO journal.

Modified leukopenic response and complement activation during dialyzer reuse.

T. Akiba, J. Takeuchi, N. Matsui, 1980, Proceedings of the Clinical Dialysis and Transplant Forum.

A case of fulminant hepatitis B followed by non A- non B posttransfusion hepatitis

Y. Hasumura, J. Takeuchi, K. Sugiura, 1980 .